Scott Summerfield

2.7k total citations
49 papers, 1.9k citations indexed

About

Scott Summerfield is a scholar working on Molecular Biology, Oncology and Spectroscopy. According to data from OpenAlex, Scott Summerfield has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Spectroscopy. Recurrent topics in Scott Summerfield's work include Drug Transport and Resistance Mechanisms (15 papers), Mass Spectrometry Techniques and Applications (11 papers) and Biosimilars and Bioanalytical Methods (11 papers). Scott Summerfield is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Mass Spectrometry Techniques and Applications (11 papers) and Biosimilars and Bioanalytical Methods (11 papers). Scott Summerfield collaborates with scholars based in United Kingdom, United States and China. Scott Summerfield's co-authors include Simon J. Gaskell, Phil Jeffrey, Árpád Somogyi, George Tsaprailis, Vicki H. Wysocki, Wenqing Zhong, Jean H. Futrell, Hari Nair, Rod A. Porter and Kevin D. Read and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Scott Summerfield

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Summerfield United Kingdom 23 694 692 510 255 232 49 1.9k
Claire Mackie Belgium 25 259 0.4× 793 1.1× 394 0.8× 371 1.5× 142 0.6× 49 2.0k
Michael B. Bolger United States 31 362 0.5× 1.3k 1.9× 687 1.3× 1.0k 4.0× 376 1.6× 77 3.9k
Markus Fridén Sweden 20 125 0.2× 442 0.6× 772 1.5× 287 1.1× 353 1.5× 40 1.7k
Christopher L. Shaffer United States 23 208 0.3× 780 1.1× 207 0.4× 386 1.5× 113 0.5× 56 1.8k
Takashi Kuwabara Japan 22 152 0.2× 883 1.3× 803 1.6× 222 0.9× 79 0.3× 56 2.2k
Christian R. Noe Austria 27 326 0.5× 1.2k 1.7× 206 0.4× 228 0.9× 48 0.2× 178 2.3k
Phil Jeffrey United Kingdom 16 66 0.1× 549 0.8× 524 1.0× 294 1.2× 207 0.9× 36 1.3k
Travis T. Wager United States 29 193 0.3× 1.7k 2.4× 419 0.8× 545 2.1× 115 0.5× 42 3.9k
Paolo Pevarello Italy 21 142 0.2× 859 1.2× 230 0.5× 219 0.9× 56 0.2× 54 1.6k
Patrick R. Verhoest United States 25 105 0.2× 1.7k 2.5× 309 0.6× 506 2.0× 66 0.3× 56 3.4k

Countries citing papers authored by Scott Summerfield

Since Specialization
Citations

This map shows the geographic impact of Scott Summerfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Summerfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Summerfield more than expected).

Fields of papers citing papers by Scott Summerfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Summerfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Summerfield. The network helps show where Scott Summerfield may publish in the future.

Co-authorship network of co-authors of Scott Summerfield

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Summerfield. A scholar is included among the top collaborators of Scott Summerfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Summerfield. Scott Summerfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Loryan, Irena, Andreas Reichel, Bo Feng, et al.. (2022). Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain—a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical Research. 39(7). 1321–1341. 62 indexed citations
3.
Summerfield, Scott, James Yates, & David Fairman. (2022). Free Drug Theory – No Longer Just a Hypothesis?. Pharmaceutical Research. 39(2). 213–222. 60 indexed citations
4.
Scott‐Stevens, Paul, Yan Chen, Jianfei Wang, et al.. (2018). Rapid Bioavailability and Disposition protocol: A novel higher throughput approach to assess pharmacokinetics and steady-state brain distribution with reduced animal usage. European Journal of Pharmaceutical Sciences. 122. 13–21. 1 indexed citations
5.
Liu, Houfu, Kelly Dong, Wandong Zhang, Scott Summerfield, & Georg C. Terstappen. (2018). Prediction of brain:blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems. Drug Discovery Today. 23(7). 1357–1372. 57 indexed citations
6.
Liu, Houfu, Liang Huang, Yi Li, et al.. (2017). Correlation between Membrane Protein Expression Levels and Transcellular Transport Activity for Breast Cancer Resistance Protein. Drug Metabolism and Disposition. 45(5). 449–456. 18 indexed citations
7.
Spooner, Neil, Stephanie Cape, & Scott Summerfield. (2017). Outsourcing Strategies in Bioanalysis. Bioanalysis. 9(15). 1125–1126. 2 indexed citations
8.
Zhang, Yanyan, Houfu Liu, Scott Summerfield, Christopher N. Luscombe, & Jasminder Sahi. (2016). Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System. Molecular Pharmaceutics. 13(5). 1540–1550. 40 indexed citations
9.
Summerfield, Scott, Yanyan Zhang, & Han Liu. (2016). Examining the Uptake of Central Nervous System Drugs and Candidates across the Blood-Brain Barrier. Journal of Pharmacology and Experimental Therapeutics. 358(2). 294–305. 48 indexed citations
10.
Summerfield, Scott, et al.. (2013). In vitro, in vivo and in silico models of drug distribution into the brain. Journal of Pharmacokinetics and Pharmacodynamics. 40(3). 301–314. 24 indexed citations
11.
Jeffrey, Phil & Scott Summerfield. (2009). Assessment of the blood–brain barrier in CNS drug discovery. Neurobiology of Disease. 37(1). 33–37. 75 indexed citations
12.
Summerfield, Scott, Adam Lucas, Rod A. Porter, et al.. (2008). Toward an improved prediction of humanin vivobrain penetration. Xenobiotica. 38(12). 1518–1535. 77 indexed citations
13.
Huntjens, Dymphy, Anne Chain, Scott Summerfield, et al.. (2008). Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats. British Journal of Pharmacology. 153(5). 1072–1084. 24 indexed citations
14.
Jeffrey, Phil & Scott Summerfield. (2007). Challenges for blood–brain barrier (BBB) screening. Xenobiotica. 37(10-11). 1135–1151. 59 indexed citations
15.
Summerfield, Scott, Kevin D. Read, David J. Begley, et al.. (2007). Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction. Journal of Pharmacology and Experimental Therapeutics. 322(1). 205–213. 225 indexed citations
16.
Summerfield, Scott & Phil Jeffrey. (2006). In vitro prediction of brain penetration – a case for free thinking?. Expert Opinion on Drug Discovery. 1(6). 595–607. 14 indexed citations
17.
Reeve, Alison J., et al.. (2006). Investigation into the role of P2X3/P2X2/3 receptors in neuropathic pain following chronic constriction injury in the rat: an electrophysiological study. British Journal of Pharmacology. 148(6). 845–852. 58 indexed citations
18.
Summerfield, Scott, Alexander J. Stevens, Leanne Cutler, et al.. (2006). Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1282–1290. 138 indexed citations
19.
Ishii, Yasuyuki, John E. Blundell, Jason C. G. Halford, et al.. (2004). Anorexia and weight loss in male rats 24h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behavioural Brain Research. 157(2). 331–341. 55 indexed citations
20.
Parmar, Virinder S., Subhash C. Jain, Amitabh Jha, et al.. (1997). SYNTHETIC AND MASS SPECTRAL FRAGMENTATION STUDIES ON TRISUBSTITUTED 2H-PYRAN-2-ONES AND COMPARATIVE EIMS BEHAVIOUR OF BIOLOGICALLY ACTIVE 3,5-DISUBSTI TUTED PYRAZOLES AND ISOXAZOLES. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 36(10). 872–879. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Mackie Breakdown of academic impact, for papers by Michael B. Bolger Breakdown of academic impact, for papers by Markus Fridén Breakdown of academic impact, for papers by Christopher L. Shaffer Breakdown of academic impact, for papers by Takashi Kuwabara Breakdown of academic impact, for papers by Christian R. Noe Breakdown of academic impact, for papers by Phil Jeffrey Breakdown of academic impact, for papers by Travis T. Wager Breakdown of academic impact, for papers by Paolo Pevarello Breakdown of academic impact, for papers by Patrick R. Verhoest
Rankless by CCL
2026